Apolo Discusses Immunotherapy Advances in Bladder Cancer – OncLive
OncLive |
Apolo Discusses Immunotherapy Advances in Bladder Cancer
OncLive Apolo, a medical oncologist at the National Cancer Institute and chief of the bladder cancer section of the Genitourinary Malignancies Branch, expressed her excitement about immunotherapy combinations in bladder cancer in an interview with OncLive at … |
